Current and historical daily PE Ratio for LZAGF (
Lonza Group Ltd
) from 1990 to Jun 18 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Lonza Group stock (LZAGF) PE ratio as of Jun 18 2024 is 54.21.
More Details
Lonza Group Ltd (LZAGF) PE Ratio (TTM) Chart
Lonza Group Ltd (LZAGF) PE Ratio (TTM) Historical Data
View and export this data going back to 1990. Start your Free Trial
Total 1252
- 1
- 2
- 3
- 4
- 5
- 6
- 14
Lonza Group PE Ratio (TTM) Historical Data | |||
---|---|---|---|
Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
2024-06-18 | 54.2 | 2024-04-15 | 57.7 |
2024-06-17 | 53.0 | 2024-04-12 | 58.6 |
2024-06-14 | 52.7 | 2024-04-11 | 58.9 |
2024-06-13 | 54.0 | 2024-04-10 | 58.1 |
2024-06-12 | 54.5 | 2024-04-09 | 60.2 |
2024-06-11 | 54.9 | 2024-04-08 | 60.2 |
2024-06-10 | 57.1 | 2024-04-05 | 60.2 |
2024-06-07 | 55.5 | 2024-04-04 | 60.5 |
2024-06-06 | 56.4 | 2024-04-03 | 61.3 |
2024-06-05 | 56.1 | 2024-04-02 | 58.5 |
2024-06-04 | 56.5 | 2024-04-01 | 59.9 |
2024-06-03 | 54.2 | 2024-03-28 | 60.1 |
2024-05-31 | 55.1 | 2024-03-27 | 59.6 |
2024-05-30 | 54.8 | 2024-03-26 | 59.1 |
2024-05-29 | 51.2 | 2024-03-25 | 58.5 |
2024-05-28 | 54.6 | 2024-03-22 | 58.3 |
2024-05-24 | 54.5 | 2024-03-21 | 58.8 |
2024-05-23 | 54.9 | 2024-03-20 | 59.3 |
2024-05-22 | 55.8 | 2024-03-19 | 54.3 |
2024-05-21 | 58.8 | 2024-03-18 | 54.1 |
2024-05-20 | 58.8 | 2024-03-15 | 55.1 |
2024-05-17 | 57.8 | 2024-03-14 | 54.3 |
2024-05-16 | 59.8 | 2024-03-13 | 53.9 |
2024-05-15 | 57.9 | 2024-03-12 | 51.7 |
2024-05-14 | 57.7 | 2024-03-11 | 52.5 |
2024-05-13 | 55.8 | 2024-03-08 | 52.8 |
2024-05-10 | 58.1 | 2024-03-07 | 53.3 |
2024-05-09 | 56.2 | 2024-03-06 | 51.7 |
2024-05-08 | 57.4 | 2024-03-05 | 51.5 |
2024-05-07 | 58.7 | 2024-03-04 | 51.8 |
2024-05-06 | 57.1 | 2024-03-01 | 53.0 |
2024-05-03 | 58.5 | 2024-02-29 | 52.0 |
2024-05-02 | 56.7 | 2024-02-28 | 52.9 |
2024-05-01 | 53.6 | 2024-02-27 | 52.9 |
2024-04-30 | 55.9 | 2024-02-26 | 51.9 |
2024-04-29 | 57.4 | 2024-02-23 | 53.2 |
2024-04-26 | 55.3 | 2024-02-22 | 52.6 |
2024-04-25 | 54.5 | 2024-02-21 | 51.4 |
2024-04-24 | 55.7 | 2024-02-20 | 51.1 |
2024-04-23 | 55.8 | 2024-02-16 | 52.6 |
2024-04-22 | 54.0 | 2024-02-15 | 52.2 |
2024-04-19 | 54.7 | 2024-02-14 | 52.5 |
2024-04-18 | 56.3 | 2024-02-13 | 49.9 |
2024-04-17 | 57.8 | 2024-02-12 | 51.8 |
2024-04-16 | 57.2 | 2024-02-09 | 51.1 |
Lonza Group Ltd (LZAGF) PE Ratio (TTM) Comparison
Company | Market Cap(Mil) | PE Ratio (TTM) |
---|
Business Description
Business Description
![Lonza Group Ltd Lonza Group Ltd logo](https://static.gurufocus.com/logos/0C00000X09.png?14)
Lonza Group Ltd
ISIN : CH0013841017
Share Class Description:
LZAGF: Ordinary SharesDescription
Lonza Group ltd is a contract development and manufacturing organization, or CDMO. It operates under four segments: small molecules, biologics, cell & gene, and capsules & health ingredients. Lonza derives its revenue primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing services throughout the entire lifecycle of a product from drug research to commercial supply. The majority of Lonza's customers are pharmaceutical and biotechnology companies, academic institutions, and government research organizations.